The Charcot Foot (Pied de Charcot)

Levin and O'Neal's The Diabetic Foot with CD-ROM

Volumn , Issue , 2007, Pages 257-283

  Sanders, Lee J ^a   Frykberg, Robert G ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85133748208     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-04145-4.50019-3     Document Type: Chapter

References (156)

1. Guillain G J.-M. Charcot 1825-1893: His Life-His Work (edited and translated by Pearce Bailey) 1959, Paul B. Hoeber, New York.
2. Charcot J-M Sur quelques arthropathies qui paraissent dépendre d'une lésion du cerveau ou de la moelle épinière. Arch Physio Norm Pathol 1868, 1:161-178.
3. Hoché G, Sanders LJ On some arthropathies apparently related to a lesion of the brain or spinal cord, by Dr. J.-M. Charcot, January 1868. J Hist Neurosci 1992, 1(1):75-87.
4. Charcot JM Lecture IV, on some visceral derangements in locomotor ataxia: Arthropathies of ataxic patients. Lectures on the Diseases of the Nervous System 1962, 47-61. Hafner, New York. G. Sigerson (Ed.).
5. Brower AC, Allman RM The neuropathic joint: A neurovascular bone disorder. Radiol Clin North Am 1981, 19(4):571-580.
6. Brower AC, Allman RM Pathogenesis of the neurotrophic joint: Neurotraumatic vs. neurovascular. Radiology 1981, 139(2):349-354.
7. Brower AC, Allman RM Neuropathic osteoarthropathy in the adult. Radiology: Diagnosis- Imaging-Intervention 1989, vol 5:1-8. JB Lippincott, Philadelphia. J.M. Traveras, J.T. Ferrucci (Eds.).
8. Delano PJ The pathogenesis of Charcot's joint. Am J Roentgenol 1946, 56:189.
9. Soto-Hall R, Halderman KO The diagnosis of neuropathic joint disease (Charcot joint): An analysis of 40 cases. JAMA 1940, 114:2076-2078.
10. Wartenberg R Neuropathic joint disease. JAMA 1938, 111:2044.
11. Frykberg RG, Kozak GP Neuropathic arthropathy in the diabetic foot. Am Fam Physician 1978, 17(5):105-113.
12. Frykberg RG Osteoarthropathy. Clin Podiatr Med Surg 1987, 4(2):351-359.
13. Miller DS, Lichtman WF Diabetic neuropathic arthropathy of feet: Summary report of seventeen cases. Arch Surg 1955, 70(4):513-518.
14. Norman A, Robbins H, Milgram JE The acute neuropathic arthropathy: A rapid, severely disorganizing form of arthritis. Radiology 1968, 90(6):1159-1164.
15. Bruckner FE, Howell A Neuropathic joints. Semin Arthritis Rheum 1972, 2(1):47-49.
16. Steindler A The tabetic arthropathies. JAMA 1931, 96:250-256.
17. Harris JR, Brand PW Patterns of disintegration of the tarsus in the anaesthetic foot. J Bone Joint Surg Br 1966, 48(1):4-16.
18. Wastie ML Radiological changes in serial x-rays of the foot and tarsus in leprosy. Clin Radiol 1975, 26(2):285-292.
19. Johnson JT Neuropathic fractures and joint injuries: Pathogenesis and rationale of prevention and treatment. J Bone Joint Surg Am 1967, 49(1):1-30.
20. Bjorkengren AG, Weisman M, Pathria MN, et al. Neuroarthropathy associated with chronic alcoholism. AJR Am J Roentgenol 1988, 51(4):743-745.
21. Mitchell SW, Morehouse GR, Keen WW Gunshot Wounds and Other Injuries of Nerves 1864, JB Lippincott, Philadelphia.
22. Kerwein G, Lyon WF Neuropathic arthropathy of the ankle joint resulting from complete severance of the sciatic nerve. Ann Surg 1942, 115:267-278.
23. Newman JH Non-infective disease of the diabetic foot. J Bone Joint Surg Br 1981, 63B(4):593-596.
24. Chantelau E The perils of procrastination: Effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med 2005, 22(12):1707-1712.
25. Jordan WR Neuritic manifestations in diabetes mellitus. Arch Intern Med 1936, 57:307-366.
26. Kelly M De arthritide symptomatica of William Musgrave (1657-1721): His description of neuropathic arthritis. Bull Hist Med J 1963, 37:372-377.
27. Mitchell JK On a new practice in acute and chronic rheumatism. Am J Med Sci 1831, 8:55-64.
28. Goetz CG, Bonduelle M, Gelfand T Charcot Constructing Neurology 1995, Oxford University Press, New York.
29. MacCormac W, Klockmann JW Transactions of the International Medical Congress: Seventh Session Held in London, August 2-9, 1881 1881, vol 1. Balantyne, Hanson, London.
30. Charcot J-M Demonstration of arthropathic affections of locomotor ataxy. BMJ 1881, 2:285.
31. Charcot J-M, Féré C Affections osseuses et articulaires du pied chez les tabétiques (pied tabétique). Archives de Neurologie 1883, 6(18):305-319.
32. Jude EB, Selby PL, Burgess J, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: A double-blind randomised controlled trial. Diabetologia 2001, 44(11):2032-2037.
33. Pitocco D, Ruotolo V, Caputo S, et al. Six-month treatment with alendronate in acute Charcot neuroarthropathy: A randomized controlled trial. Diabetes Care 2005, 28(5):1214-1215.
34. Jeffcoate WJ, Game F, Cavanagh PR The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet 2005, 366(9502):2058-2061.
35. Jeffcoate WJ Abnormalities of vasomotor regulation in the pathogenesis of the acute charcot foot of diabetes mellitus. Int J Low Extrem Wounds 2005, 4(3):133-137.
36. Foster AV Problems with the nomenclature of Charcot's osteoarthropathy. Diabetic Foot 2005, 8(3).
37. Charcotian eponyms. South Med J 1975, 68(12):1592.
38. Bailey CC, Root HF Neuropathic foot lesions in diabetes mellitus. N Engl J Med 1947, 236(11):397-401.
39. Forgacs S Clinical picture of diabetic osteoarthropathy. Acta Diabetol Lat 1976, 3(3-4):111-129.
40. Pogonowska MJ, Collins LC, Dobson HL Diabetic osteopathy. Radiology 1967, 89:265-271.
41. Sinha S, Munichoodappa CS, Kozak GP Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases). Medicine (Baltimore) 1972, 51(3):191-210.
42. Cofield RH, Morrison MJ, Beabout JW Diabetic neuroarthropathy in the foot: Patient characteristics and patterns of radiographic change. Foot Ankle 1983, 4(1):15-22.
43. Lavery LA, Armstrong DG, Wunderlich RP, et al. Diabetic foot syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003, 26(5):1435-1438.
44. Armstrong DG, Todd WF, Lavery LA, et al. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. J Am Podiatr Med Assoc 1997, 87(6):272-278.
45. Clohisy DR, Thompson RC Fractures associated with neuropathic arthropathy in adults who have juvenile-onset diabetes. J Bone Joint Surg Am 1988, 70(8):1192-1200.
46. Clouse ME, Gramm HF, Legg M, Flood T Diabetic osteoarthropathy: Clinical and roentgenographic observations in 90 cases. Am J Roentgenol Radium Ther Nucl Med 1974, 121(1):22-34.
47. Sanders LJ, Mrdjenovich D Anatomical patterns of bone and joint destruction in neuropathic diabetics. Diabetes 1991, 40(suppl 1):529A.
48. Frykberg RG, Kozak GP The diabetic Charcot foot. Management of Diabetic Foot Problems 1995, 88-97. WB Saunders, Philadelphia. 2nd ed. G.P. Kozak, D.R. Campbell, R.G. Frykberg, G.M. Habershaw (Eds.).
49. Sanders LJ, Frykberg RG Diabetic neuropathic osteoarthropathy: The Charcot foot. The High Risk Foot in Diabetes Mellitus 1991, 297-338. Churchill Livingstone, New York. R.G. Frykberg (Ed.).
50. Schwarz GS, Berenyi MR, Siegel MW Atrophic arthropathy and diabetic neuritis. Am J Roentgenol Radium Ther Nucl Med 1969, 106(3):523-529.
51. Gough A, Abraha H, Li F, et al. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy. Diabet Med 1997, 14(7):527-531.
52. Newman JH Spontaneous dislocation in diabetic neuropathy: A report of six cases. J Bone Joint Surg Br 1979, 61-B(4):484-488.
53. Eichenholtz SN Charcot Joints 1966, Charles C. Thomas, Springfield, IL.
54. Shibata T, Tada K, Hashizume C The results of arthrodesis of the ankle for leprotic neuroarthropathy. J Bone Joint Surg Am 1990, 72(5):749-756.
55. Sella EJ, Barrette C Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient. J Foot Ankle Surg 1999, 38(1):34-40.
56. Rogers A, Eastell R Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: Clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005, 90(11):6323-6331.
57. Rogers A, Saleh G, Hannon RA, et al. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab 2002, 87(10):4470-4475.
58. Schett G, Kiechl S, Redlich K, et al. Soluble RANKL and risk of nontraumatic fracture. JAMA 2004, 291(9):1108-1113.
59. Jeffcoate W Vascular calcification and osteolysis in diabetic neuropathy: Is RANK-L the missing link?. Diabetologia 2004, 47(9):1488-1492.
60. Treves F Treatment of perforating ulcer of the foot. Lancet 1884, 2:949.
61. Beltran J, Campanini DS, Knight C, McCalla M The diabetic foot: Magnetic resonance imaging evaluation. Skeletal Radiol 1990, 19(1):37-41.
62. Blume PA, Dey HM, Daley LJ, et al. Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. J Foot Ankle Surg 1997, 36(2):120-126. discussion 160,.
63. Johnson JE, Kennedy EJ, Shereff MJ, et al. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int 1996, 17(1):10-16.
64. Milgram JW Osteomyelitis in the foot and ankle associated with diabetes mellitus. Clin Orthop Relat Res 1993, 296:50-57.
65. Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: Comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int 2004, 25(12):890-895.
66. Berendt AR, Lipsky B Is this bone infected or not?: Differentiating neuro-osteoarthropathy from osteomyelitis in the diabetic foot. Curr Diab Rep 2004, 4(6):424-429.
67. Lippmann HI, Perotto A, Farrar R The neuropathic foot of the diabetic. Bull N Y Acad Med 1976, 52(10):1159-1178.
68. Martin M Charcot joints in diabetes mellitus. Proc R Soc Med 1952, 45:503-506.
69. Martin MM Diabetic neuropathy: A clinical study of 150 cases. Brain 1953, 176:594.
70. Brooks AP The neuropathic foot in diabetes: II. Charcot's neuroarthropathy. Diabet Med 1986, 3(2):116-118.
71. Young MJ, Marshall A, Adams JE, et al. Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy. Diabetes Care 1995, 18(1):34-38.
72. Archer AG, Roberts VC, Watkins PJ Blood flow patterns in diabetic neuropathy. Diabetologia 1984, 27:563.
73. Edelman SV, Kosofsky EM, Paul RA, Kozak GP Neuroosteoarthropathy (Charcot's joint) in diabetes mellitus following revascularization surgery: Three case reports and a review of the literature. Arch Intern Med 1987, 147(8):1504-1508.
74. Edmonds ME, Nicolaides KH, Watkins PJ Autonomic neuropathy and diabetic foot ulceration. Diabet Med 1986, 3(1):56-59.
75. Lister J, Maudsley RH Charcot joints in diabetic neuropathy. Lancet 1951, 2:1110.
76. El-Khoury GY, Kathol MH Neuropathic fractures in patients with diabetes mellitus. Radiology 1980, 134:313-316.
77. Grant WP, Foreman EJ, Wilson AS, et al. Evaluation of Young's modulus in Achilles tendons with diabetic neuroarthropathy. J Am Podiatr Med Assoc 2005, 95(3):242-246.
78. Banks AS, McGlamry ED Charcot foot. J Am Podiatr Med Assoc 1989, 79(5):213-235.
79. Craig JG, Amin MB, Wu K, et al. Osteomyelitis of the diabetic foot: MR imaging-pathologic correlation. Radiology 1997, 203(3):849-855.
80. Lavery LA, Higgins KR, Lanctot DR, et al. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004, 27(11):2642-2647.
81. Kelly PJ, Coventry MB Neurotrophic ulcers of the feet: Review of forty-seven cases. J Am Med Assoc 1958, 168(4):388-393.
82. Boulton AJ, Scarpello JH, Ward JD Venous oxygenation in the diabetic neuropathic foot: Evidence of arteriovenous shunting?. Diabetologia 1982, 22(1):6-8.
83. Cundy TF, Edmonds ME, Watkins PJ Osteopenia and metatarsal fractures in diabetic neuropathy. Diabet Med 1985, 2(6):461-464.
84. Edmonds ME, Clarke MB, Newton S, et al. Increased uptake of bone radiopharmaceutical in diabetic neuropathy. Q J Med 1985, 57(224):843-855.
85. Edmonds ME The neuropathic foot in diabetes: I. Blood flow. Diabet Med 1986, 3(2):111-115.
86. Forst T, Pfutzner A, Kann P, et al. Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet Med 1995, 12(10):874-879.
87. Watkins PJ, Edmonds ME Sympathetic nerve failure in diabetes. Diabetologia 1983, 25(2):73-77.
88. Radin EL Mechanical aspects of osteoarthrosis. Bull Rheum Dis 1976, 26(7):862-865.
89. Arntz CT, Veith RG, Hansen ST Fractures and fracture-dislocations of the tarsometatarsal joint. J Bone Joint Surg Am 1988, 70(2):173-181.
90. Armstrong DG, Lavery LA Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg Am 1998, 80(3):365-369.
91. Cavanagh PR, Sims DS, Sanders LJ Body mass is a poor predictor of peak plantar pressure in diabetic men. Diabetes Care 1991, 14(8):750-755.
92. Caputo GM, Cavanagh PR, Ulbrecht JS, et al. Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994, 331(13):854-860.
93. Holmes GB, Hill N Fractures and dislocations of the foot and ankle in diabetics associated with Charcot joint changes. Foot Ankle Int 1994, 15(4):182-185.
94. Cavanagh PR, Young MJ, Adams JE, et al. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care 1994, 17(3):201-209.
95. Grant WP, Sullivan R, Sonenshine DE, et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg 1997, 36(4):272-278. discussion 330,.
96. Frykberg RG Biomechanical considerations of the diabetic foot. Lower Extremity 1995, 2:207-214.
97. Schoenhaus HD, Wernick E, Cohen R Biomechanics of the diabetic foot. The High Risk Foot in Diabetes Mellitus 1991, Churchill Livingstone, New York. R.G. Frykberg (Ed.).
98. Brink SJ Limited joint mobility as a risk factor for diabetes complications. Clin Diabetes 1987, 5:122.
99. Brownlee M, Cerami A, Vlassara H: Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318(20):1315-1321.
100. Buckingham BA, Uitto J, Sandborg C, et al. Scleroderma-like changes in insulin-dependent diabetes mellitus: Clinical and biochemical studies. Diabetes Care 1984, 7(2):163-169.
101. Monnier VM, Glomb M, Elgawish A, Sell DR The mechanism of collagen cross-linking in diabetes: A puzzle nearing resolution. Diabetes 1996, 45(suppl 3):S67-S72.
102. Monnier VM, Vishwanath V, Frank KE, et al. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986, 314(7):403-408.
103. Delbridge L, Perry P, Marr S, et al. Limited joint mobility in the diabetic foot: Relationship to neuropathic ulceration. Diabet Med 1988, 5(4):333-337.
104. Fernando DJ, Masson EA, Veves A, Boulton AJ Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991, 14(1):8-11.
105. Mueller MJ, Diamond JE, Delitto A, Sinacore DR Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther 1989, 69(6):453-459. discussion 459-462,.
106. Jirkovska A, Kasalicky P, Boucek P, et al. Calcaneal ultrasonometry in patients with Charcot osteoarthropathy and its relationship with densitometry in the lumbar spine and femoral neck and with markers of bone turnover. Diabet Med 2001, 18(6):495-500.
107. Petrova NL, Foster AV, Edmonds ME Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: Differences between Type 1 and Type 2 diabetes. Diabet Med 2005, 22(6):756-761.
108. Herbst SA, Jones KB, Saltzman CL Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br 2004, 86(3):378-383.
109. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. J Am Med Assoc 1991, 266(9):1246-1251.
110. Kraft E, Spyropoulos E, Finby N Neurogenic disorders of the foot in diabetes mellitus. Am J Roentgenol Radium Ther Nucl Med 1975, 124(1):17-24.
111. Lesko P, Maurer RC Talonavicular dislocations and midfoot arthropathy in neuropathic diabetic feet: Natural course and principles of treatment. Clin Orthop Relat Res 1989, 240:226-231.
112. Thompson RC Jr, Havel P, Goetz F: Presumed neurotrophic skeletal disease in diabetic kidney transplant recipients. J Am Med Assoc 249(10):1317-1319.
113. Rubinow A, Spark EC, Canoso JJ Septic arthritis in a Charcot joint. Clin Orthop Relat Res 1980, 147:203-206.
114. Kathol MH, el-Khoury GY, Moore TE, Marsh JL Calcaneal insufficiency avulsion fractures in patients with diabetes mellitus. Radiology 1991, 180(3):725-729.
115. Coventry MB, Rothacker GW Bilateral calcaneal fracture in a diabetic patient: A case report. J Bone Joint Surg Am 1979, 61(3):462-464.
116. Biehl WC, Morgan JM, Wagner FW, Gabriel R Neuropathic calcaneal tuberosity avulsion fractures. Clin Orthop Relat Res 1993, 296:8-13.
117. Brodsky JW, Rouse AM Exostectomy for symptomatic bony prominences in diabetic charcot feet. Clin Orthop Relat Res 1993, 296:21-26.
118. Schon LC, Easley ME, Cohen I, et al. The acquired midtarsus deformity classification system: Interobserver reliability and intraobserver reproducibility. Foot Ankle Int 2002, 23(1):30-36.
119. Schon LC, Weinfeld SB, Horton GA, Resch S Radiographic and clinical classification of acquired midtarsus deformities. Foot Ankle Int 1998, 19(6):394-404.
120. Ledermann HP, Morrison WB Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR imaging. Semin Musculoskelet Radiol 2005, 9(3):272-283.
121. Williamson BR, Teates CD, Phillips CD, Croft BY Computed tomography as a diagnostic aid in diabetic and other problem feet. Clin Imaging 1989, 13(2):159-163.
122. Seabold JE, Flickinger FW, Kao SC, et al. Indium-111-leukocyte/ technetium-99m-MDP bone and magnetic resonance imaging: Difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med 1990, 31(5):549-556.
123. Schauwecker DS, Park HM, Burt RW, et al. Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med 1988, 29(10):1651-1655.
124. Edmonds ME, Morrison N, Laws JW, Watkins PJ Medial arterial calcification and diabetic neuropathy. Br Med J (Clin Res Ed) 1982, 284(6320):928-930.
125. Eymontt MJ, Alavi A, Dalinka MK, Kyle GC Bone scintigraphy in diabetic osteoarthropathy. Radiology 1981, 140(2):475-477.
126. Hart TJ, Healey K Diabetic osteoarthropathy versus diabetic osteomyelitis. J Foot Surg 1986, 25(6):464-468.
127. Glynn TP Marked gallium accumulation in neurogenic arthropathy. J Nucl Med 1981, 22(11):1016-1017.
128. Hartshorne MF, Peters V Nuclear medicine applications for the diabetic foot. Clin Podiatr Med Surg 1987, 4(2):361-375.
129. Maurer AH, Millmond SH, Knight LC, et al. Infection in diabetic osteoarthropathy: Use of indium-labeled leukocytes for diagnosis. Radiology 1986, 161(1):221-225.
130. Schauwecker DS Osteomyelitis: Diagnosis with In-111-labeled leukocytes. Radiology 1989, 171(1):141-146.
131. Zeiger LS, Fox IM Use of indium-111-labeled white blood cells in the diagnosis of diabetic foot infections. J Foot Surg 1990, 29(1):46-51.
132. Keenan AM, Tindel NL, Alavi A Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Int Med 1989, 149:2262.
133. Armstrong DG, Lavery LA, Liswood PJ, et al. Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther 1997, 77(2):169-175. discussion 176-167,.
134. Shaw JE, Hsi WL, Ulbrecht JS, et al. The mechanism of plantar unloading in total contact casts: Implications for design and clinical use. Foot Ankle Int 1997, 18(12):809-817.
135. Guse ST, Alvine FG Treatment of diabetic foot ulcers and Charcot neuroarthropathy using the patellar tendon-bearing brace. Foot Ankle Int 1997, 18(10):675-677.
136. Saltzman CL, Johnson KA, Goldstein RH, Donnelly RE The patellar tendon-bearing brace as treatment for neurotrophic arthropathy: A dynamic force monitoring study. Foot Ankle 1992, 13(1):14-21.
137. Lavery LA, Vela SA, Lavery DC, Quebedeaux TL Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations: A comparison of treatments. Diabetes Care 1996, 19(8):818-821.
138. Baumhauer JF, Wervey R, McWilliams J, et al. A comparison study of plantar foot pressure in a standardized shoe, total contact cast, and prefabricated pneumatic walking brace. Foot Ankle Int 1997, 18(1):26-33.
139. Fleischli JG, Lavery LA, Vela SA, et al. 1997 William J. Stickel Bronze Award: Comparison of strategies for reducing pressure at the site of neuropathic ulcers. J Am Podiatr Med Assoc 1997, 87(10):466-472.
140. Landsman AS, Sage R Off-loading neuropathic wounds associated with diabetes using an ankle-foot orthosis. J Am Podiatr Med Assoc 1997, 87(8):349-357.
141. Morgan JM, Biehl WC, Wagner FW Management of neuropathic arthropathy with the Charcot Restraint Orthotic Walker. Clin Orthop Relat Res 1993, 296:58-63.
142. Cavanagh P, Sanders LJ, Sims DS The role of pressure distribution measurement in diabetic foot care: Rehabilitation R&D progress reports 1987. J Rehab Res Dev 1988, 25:53-54.
143. Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995, 18(10):1376-1378.
144. Ashry HR, Lavery LA, Murdoch DP, et al. Effectiveness of diabetic insoles to reduce foot pressures. J Foot Ankle Surg 1997, 36(4):268-271. discussion 328-269,.
145. Lavery LA, Vela SA, Fleischli JG, et al. Reducing plantar pressure in the neuropathic foot: A comparison of footwear. Diabetes Care 1997, 20(11):1706-1710.
146. Rogers MJ New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 2003, 9(32):2643-2658.
147. Kirk JK, Spangler JG Alendronate: A bisphosphonate for treatment of osteoporosis. Am Fam Physician 1996, 54:2053-2060.
148. Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999, 282(14):1344-1352.
149. Liberman UA, Weiss SR, Broll J, et al. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis: The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995, 333(22):1437-1443.
150. Selby PL, Young MJ, Boulton AJ Bisphosphonates: A new treatment for diabetic Charcot neuroarthropathy?. Diabet Med 1994, 11(1):28-31.
151. Kaskani E, Lyritis GP, Kosmidis C, et al. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: A pilot study. Clin Rheumatol 2005, 24(3):232-238.
152. Lyritis G, Boscainos PJ Calcitonin effects on cartilage and fracture healing. J Musculoskelet Neuronal Interact 2001, 2(2):137-142.
153. Mendicino RW, Catanzariti AR, Saltrick KR, et al. Tibiotalocalcaneal arthrodesis with retrograde intramedullary nailing. J Foot Ankle Surg 2004, 43(2):82-86.
154. Jani MM, Ricci WM, Borrelli J, et al. A protocol for treatment of unstable ankle fractures using transarticular fixation in patients with diabetes mellitus and loss of protective sensibility. Foot Ankle Int 2003, 24(11):838-844.
155. Pinzur M Surgical versus accommodative treatment for Charcot arthropathy of the midfoot. Foot Ankle Int 2004, 25(8):545-549.
156. Kidd JG The Charcot joint: some pathologic and pathogenetic considerations. South Med J 1974, 67(5):597-602.